BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 25588886)

  • 1. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.
    Santos AS; Finlay BB
    Cell Microbiol; 2015 Mar; 17(3):318-32. PubMed ID: 25588886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Yen H; Karino M; Tobe T
    Front Cell Infect Microbiol; 2016; 6():89. PubMed ID: 27617233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue.
    Nobe R; Nougayrède JP; Taieb F; Bardiau M; Cassart D; Navarro-Garcia F; Mainil J; Hayashi T; Oswald E
    Microbiology (Reading); 2009 Oct; 155(Pt 10):3214-3225. PubMed ID: 19628559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coli.
    Jayamani E; Mylonakis E
    Virulence; 2014; 5(7):733-9. PubMed ID: 25513774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation.
    Yen H; Sugimoto N; Tobe T
    PLoS Pathog; 2015 Sep; 11(9):e1005121. PubMed ID: 26332984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.
    Wong AR; Pearson JS; Bright MD; Munera D; Robinson KS; Lee SF; Frankel G; Hartland EL
    Mol Microbiol; 2011 Jun; 80(6):1420-38. PubMed ID: 21488979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Host Cell Processes by T3SS Effectors.
    Shenoy AR; Furniss RCD; Goddard PJ; Clements A
    Curr Top Microbiol Immunol; 2018; 416():73-115. PubMed ID: 30178263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F
    Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
    Thanabalasuriar A; Kim J; Gruenheid S
    Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell death response to enteropathogenic Escherichia coli infection.
    Wong Fok Lung T; Pearson JS; Schuelein R; Hartland EL
    Cell Microbiol; 2014 Dec; 16(12):1736-45. PubMed ID: 25266336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotypes and virutypes of enteropathogenic and enterohaemorrhagic Escherichia coli strains from stool samples of children with diarrhoea in Germany.
    Kozub-Witkowski E; Krause G; Frankel G; Kramer D; Appel B; Beutin L
    J Appl Microbiol; 2008 Feb; 104(2):403-10. PubMed ID: 17887989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attaching and effacing pathogens: the effector ABC of immune subversion.
    Riebisch AK; Mühlen S
    Future Microbiol; 2020 Jul; 15():945-958. PubMed ID: 32716209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
    El Qaidi S; Wu M; Zhu C; Hardwidge PR
    Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host cell attachment elicits posttranscriptional regulation in infecting enteropathogenic bacteria.
    Katsowich N; Elbaz N; Pal RR; Mills E; Kobi S; Kahan T; Rosenshine I
    Science; 2017 Feb; 355(6326):735-739. PubMed ID: 28209897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of virulence factors on host inflammatory response induced by diarrheagenic Escherichia coli pathotypes.
    Sanchez-Villamil J; Navarro-Garcia F
    Future Microbiol; 2015; 10(6):1009-33. PubMed ID: 26059623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.
    Shames SR; Deng W; Guttman JA; de Hoog CL; Li Y; Hardwidge PR; Sham HP; Vallance BA; Foster LJ; Finlay BB
    Cell Microbiol; 2010 Sep; 12(9):1322-39. PubMed ID: 20374249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment and membrane interactions of host cell proteins during attachment of enteropathogenic and enterohaemorrhagic Escherichia coli.
    Munera D; Martinez E; Varyukhina S; Mahajan A; Ayala-Sanmartin J; Frankel G
    Biochem J; 2012 Aug; 445(3):383-92. PubMed ID: 22587461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tip of the Iceberg: On the Roles of Regulatory Small RNAs in the Virulence of Enterohemorrhagic and Enteropathogenic
    Bhatt S; Egan M; Jenkins V; Muche S; El-Fenej J
    Front Cell Infect Microbiol; 2016; 6():105. PubMed ID: 27709103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.